Alain MBA - AB Science Chairman, CoFounder
AB Stock | EUR 1.55 0.01 0.64% |
Insider
Alain MBA is Chairman, CoFounder of AB Science SA
Phone | 33 1 47 20 00 14 |
Web | https://www.ab-science.com |
AB Science Management Efficiency
The company has return on total asset (ROA) of (0.4329) % which means that it has lost $0.4329 on every $100 spent on assets. This is way below average. AB Science's management efficiency ratios could be used to measure how well AB Science manages its routine affairs as well as how well it operates its assets and liabilities.AB Science SA has accumulated 14.44 M in total debt with debt to equity ratio (D/E) of 102.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AB Science SA has a current ratio of 1.06, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist AB Science until it has trouble settling it off, either with new capital or with free cash flow. So, AB Science's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AB Science SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AB Science to invest in growth at high rates of return. When we think about AB Science's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
Thomas Baetz | Genfit | 49 | |
Marc Bonneville | Innate Pharma | 63 | |
Laurent Lannoo | Genfit | 53 | |
Elsa Borghi | Nanobiotix SA | N/A | |
Mondher MD | Innate Pharma | 65 | |
Grgory Meiffren | Adocia | N/A | |
Earl Bergey | Nanobiotix SA | 68 | |
Valrie Danaguezian | Adocia | N/A | |
Alain Dostie | Nanobiotix SA | N/A | |
Pascal Prigent | Genfit | 55 | |
DVM MBA | Innate Pharma | 58 | |
Stefanie Magner | Genfit | 42 | |
Bart Rhijn | Nanobiotix SA | N/A | |
Pascal Caisey | Genfit | 55 | |
AnneJuliette MA | Nanobiotix SA | 49 | |
Alessandro MD | Innate Pharma | N/A | |
Brandon Owens | Nanobiotix SA | N/A | |
Jean Fourni | Innate Pharma | N/A | |
Franois Romagn | Innate Pharma | 59 | |
Pr Staels | Genfit | 60 | |
Emilie Desodt | Genfit | 40 |
Management Performance
Return On Asset | -0.43 |
AB Science SA Leadership Team
Elected by the shareholders, the AB Science's board of directors comprises two types of representatives: AB Science inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AB Science. The board's role is to monitor AB Science's management team and ensure that shareholders' interests are well served. AB Science's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AB Science's outside directors are responsible for providing unbiased perspectives on the board's policies.
Harshad KULKARNI, Head Statistics | ||
Alain MBA, Chairman, CoFounder | ||
Yves MD, Head Pharmacovigilance | ||
Laurent MBA, Chief Officer | ||
Alexis BERNARD, Head Sales | ||
Albert DVM, Pres Operations | ||
Christian FASSOTTE, Global Officer |
AB Science Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AB Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -0.43 | |||
Operating Margin | (12.22) % | |||
Current Valuation | 427.66 M | |||
Shares Outstanding | 46.86 M | |||
Shares Owned By Insiders | 41.25 % | |||
Shares Owned By Institutions | 1.79 % | |||
Price To Earning | (10.99) X | |||
Price To Sales | 193.66 X | |||
Revenue | 1.61 M | |||
Gross Profit | 1.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in AB Science Stock
AB Science financial ratios help investors to determine whether AB Science Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AB Science with respect to the benefits of owning AB Science security.